224 related articles for article (PubMed ID: 20515403)
1. Sustained release of hydroxycamptothecin after subcutaneous administration using a novel phospholipid complex-DepoFoam technology.
Zhao Y; Liu J; Sun X; Zhang ZR; Gong T
Drug Dev Ind Pharm; 2010 Jul; 36(7):823-31. PubMed ID: 20515403
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of tramadol PEG-coated multivesicular liposomes for sustained release.
He S; Zhu J; Xie F
Pharmazie; 2010 Jul; 65(7):467-70. PubMed ID: 20662312
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
4. Multivesicular liposome (MVL) sustained delivery of a novel synthetic cationic GnRH antagonist for prostate cancer treatment.
Wang T; Gao L; Quan D
J Pharm Pharmacol; 2011 Jul; 63(7):904-10. PubMed ID: 21635255
[TBL] [Abstract][Full Text] [Related]
5. [Study on liver targeting and sustained release hydroxycamptothecin polybutylcyanoacrylate nanoparticles].
Zhang ZR; Lu W
Yao Xue Xue Bao; 1997; 32(3):222-7. PubMed ID: 11327027
[TBL] [Abstract][Full Text] [Related]
6. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of cisplatin multivesicular liposomes and release of cisplatin from the liposomes in vitro].
Xiao CJ; Qi XR; Aini W; Wei SL
Yao Xue Xue Bao; 2003 Feb; 38(2):133-7. PubMed ID: 12778750
[TBL] [Abstract][Full Text] [Related]
8. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
[TBL] [Abstract][Full Text] [Related]
9. Multivesicular liposomes for the sustained release of thymopentin: stability, pharmacokinetics and pharmacodynamics.
Zuo J; Gong T; Sun X; Huang Y; Peng Q; Zhang Z
Pharmazie; 2012 Jun; 67(6):507-12. PubMed ID: 22822538
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
[TBL] [Abstract][Full Text] [Related]
11. Sustained-release hydroxycamptothecin polybutylcyanoacrylate nanoparticles as a liver targeting drug delivery system.
Sun X; Wu F; Lu W; Zhang ZR
Pharmazie; 2004 Oct; 59(10):791-4. PubMed ID: 15544059
[TBL] [Abstract][Full Text] [Related]
12. Multivesicular liposome formulation for the sustained delivery of breviscapine.
Zhong H; Deng Y; Wang X; Yang B
Int J Pharm; 2005 Sep; 301(1-2):15-24. PubMed ID: 16023316
[TBL] [Abstract][Full Text] [Related]
13. Multivesicular liposomes for sustained release of naltrexone hydrochloride: design, characterization and in vitro/in vivo evaluation.
Sun L; Wang T; Gao L; Quan D; Feng D
Pharm Dev Technol; 2013; 18(4):828-33. PubMed ID: 22759074
[TBL] [Abstract][Full Text] [Related]
14. Multivesicular liposome formulations for the sustained delivery of ropivacaine hydrochloride: preparation, characterization, and pharmacokinetics.
Shen Y; Ji Y; Xu S; Chen DQ; Tu J
Drug Deliv; 2011 Jul; 18(5):361-6. PubMed ID: 21428705
[TBL] [Abstract][Full Text] [Related]
15. [Study on preparation and tissue distribution of hydroxycamptothecin liposomes].
Zhao Z; Xie J; Liu W; Zhou J
Zhongguo Zhong Yao Za Zhi; 2011 Feb; 36(4):450-4. PubMed ID: 21598539
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
[TBL] [Abstract][Full Text] [Related]
17. Preparation and
Zhou T; Tang X; Zhang W; Feng J; Wu W
Drug Deliv; 2019 Dec; 26(1):673-679. PubMed ID: 31266376
[TBL] [Abstract][Full Text] [Related]
18. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin.
Hong M; Zhu S; Jiang Y; Tang G; Pei Y
J Control Release; 2009 Jan; 133(2):96-102. PubMed ID: 18840485
[TBL] [Abstract][Full Text] [Related]
19. Novel colon-specific microspheres with highly dispersed hydroxycamptothecin cores: their preparation, release behavior, and therapeutic efficiency against colonic cancer.
Lu B; Zhang Z
J Pharm Sci; 2006 Dec; 95(12):2619-30. PubMed ID: 16917869
[TBL] [Abstract][Full Text] [Related]
20. Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes.
Zhou T; Zhang W; Cheng D; Tang X; Feng J; Wu W
Int J Nanomedicine; 2020; 15():2277-2286. PubMed ID: 32280220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
